Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aclaris Therapts (NQ: ACRS )

21.12 USD -0.19 (-0.89%)
Streaming Delayed Price Updated: 2:15 PM EST, Mar 8, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Aclaris Therapts

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
10 Biggest Price Target Changes For Thursday
Needham lowered Splunk Inc. (NASDAQ: SPLK) price target from $275 to $265. Splunk shares rose 3.7% to $148.50 in pre-market ... 
Tags NLSN Price Target Market News
From Benzinga
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update
From GlobeNewswire News Releases
Aclaris Therapeutics to Participate in Upcoming Investor Conferences
From GlobeNewswire News Releases
Aclaris Therapeutics to Participate in the 10th Annual SVB Leerink Global Healthcare Conference
From GlobeNewswire News Releases
Frazier Healthcare Partners Adds Highly Experienced Investor to Life Sciences Team
Frazier Healthcare Partners announced the planned addition of Albert Cha, M.D., Ph.D. as Managing Partner on the Life Sciences team. He has over 20 years of experience investing in public and private... 
From Business Wire News Releases
Gaining Ground After A Tough Couple Of Weeks
After a tumultuous start to the year, things have finally started to turn around in my day trading accounts. While it’s a low bar, ... 
Tags Warrior Trading General Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers VYNE Therapeutics (NASDAQ:VYNE) shares moved upwards by 37.5% to $2.58 during Monday's regular session. ... 
Tags BZI/TFM Market News GRTS
From Benzinga
Investors Snag ACRS Even Cheaper Than Its Secondary Stock Offering
Looking back to 2 days ago, Aclaris Therapeutics Inc (ACRS) priced a 5,483,714 share secondary stock offering at $17.50 per share. Buyers in that offering made a considerable investment into the... 
Tags Stocks
From Market News Video
The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Offerings CELH DMTK
From Benzinga
10 Biggest Price Target Changes For Wednesday
UBS boosted Netflix Inc (NASDAQ: NFLX) price target from $540 to $650. Netflix shares rose 13.6% to $570.03 in pre-market ... 
Tags BE GBT Price Target
From Benzinga
Aclaris Announces Pricing of Public Offering of Common Stock
From GlobeNewswire News Releases
Aclaris Therapeutics Soars After Promising Study Against Rheumatoid Arthritis
During the trading day yesterday, Aclaris Therapeutics’ stock shot upwards with a rise of more than 200%. 
Tags Pharma/Biotech Stocks / Equities Healthcare
From Blogs - TalkMarkets
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags CLLS KLDO BIVI
From Benzinga
77 Biggest Movers From Yesterday
Gainers Gritstone Oncology, Inc. (NASDAQ: GRTS) shares jumped 248.5% to close at $22.27 on Tuesday after the company announced ... 
Tags GEVO AIRG ACOR
From Benzinga
Best Penny Stocks To Buy Right Now? 5 For Your January Watch List
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Aclaris Announces Proposed Public Offering of Common Stock
From GlobeNewswire News Releases
Mid-Afternoon Market Update: Nasdaq Surges 1.5%; Aclaris Therapeutics Shares Spike Higher
Toward the end of trading Tuesday, the Dow traded up 0.42% to 30,944.82 while the NASDAQ rose 1.50% to 13,193.24. The S&P also rose, ... 
Tags TCCO Mid/Afternoon Market Update News
From Benzinga
Why Aclaris Therapeutics Stock Skyrocketed More Than 200% Today
Investors are excited about the biotech's clinical trial results. 
Tags ACRS Market News
From Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Aclaris Therapeutics (NASDAQ:ACRS) shares rose 194.21% to $17.3 during Tuesday's regular session. Trading ... 
Tags Top Gainers Intraday Update Markets
From Benzinga
Mid-Day Market Update: Crude Oil Rises Over 1%; ProPhase Labs Shares Plummet
Midway through trading Tuesday, the Dow traded up 0.36% to 30,924.60 while the NASDAQ rose 0.84% to 13,108.03. The S&P also rose, ... 
Tags News TCCO TRXC
From Benzinga
50 Stocks Moving In Tuesday's Mid-Day Session
Gainers Aclaris Therapeutics, Inc. (NASDAQ: ACRS) shares climbed 164.3% to $15.54 after the company reported positive preliminary ... 
Tags CLXT ACOR EH
From Benzinga
ACRS Stock Alert: Why Aclaris Therapeutics Is Up Over 200% Today
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Aclaris Therapeutics (ACRS) stock is soaring higher on Tuesday after... 
Tags Market News Today's Market NASDAQ:ACRS
From InvestorPlace
Why Aclaris, Tenax, Gritstone, Merus, Minerva And Celyad Are Rallying Today
A slew of biopharma stocks are making big moves Tuesday on the back of clinical trial readouts as well announcements regarding M&A ... 
Tags LLY Trading Ideas Health Care
From Benzinga
Mid-Morning Market Update: Markets Open Higher; Goldman Sachs Earnings Top Views
Following the market opening Tuesday, the Dow traded up 0.32% to 30,914.29 while the NASDAQ rose 0.90% to 13,114.92. The S&P also ... 
Tags PRPH Market News Small Cap
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Tenax Therapeutics (NASDAQ:TENX) shares moved upwards by 75.28% to $3.12 during Tuesday's pre-market ... 
Tags GRTS PRPH Market News
From Benzinga
Aclaris Therapeutics Announces Positive Preliminary Topline Data from 12-Week Phase 2a Trial of Oral ATI-450 for Moderate to Severe Rheumatoid Arthritis
From GlobeNewswire News Releases
The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Benzinga PFE ALKS
From Benzinga
Stocks That Hit 52-Week Highs On Monday
This morning 301 companies reached new 52-week highs. Significant Points: The largest company by market cap to break ... 
Tags DE XPER TMUS
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Bellicum Pharmaceuticals (NASDAQ:BLCM) shares rose 9.91% to $4.1 during Wednesday's after-market session. Trading volume ... 
Tags Benzinga JAGX ACRS
From Benzinga
The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ACRS FOLD PLXP
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.